Supporting Nutritional Health in Patients Using Antiobesity Medications: Clinical Guidance
With ≥15% weight loss from AOMs like semaglutide and tirzepatide, nutritional guidance is critical. Almandoz et al. (2024) provide practical recommendations on protein intake, micronutrient monitoring, and individualized care—helping clinicians support long-term success and patient well-being.